相关实验视频
Updated: Jul 3, 2025
09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
7.4K
微RNA疗法的试验和考验
Attila A Seyhan1,2,3,4
1Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, RI 02912, USA.
International journal of molecular sciences
|February 10, 2024
概括
微RNA (miRNA) 疗法在癌症治疗方面表现有前途,但在传递,特异性和毒性方面的挑战阻碍了临床进展. 进一步的研究对于它们的成功应用至关重要.
科学领域:
- 生物技术和制药科学 生物技术和制药科学
- 在瘤学瘤学.
- 分子医学是分子医学.
背景情况:
- 微RNA (miRNA) 越来越多地被认为对人类疾病,特别是癌症的作用,引发了对基于miRNA的疗法的兴趣.
- mRNA疫苗的成功推动了基于RNA的免疫疗法的研究,包括用于癌症治疗的miRNA方法.
- 在RNA化学和输送系统的进步是开发可适应和模块化的RNA治疗的关键.
研究的目的:
- 探索微RNAs (miRNAs) 作为一种用于各种疾病,特别是癌症的新型药物类别的潜力.
- 审查临床开发中基于miRNA的治疗方法的当前状态,挑战和未来方向.
- 强调需要解决技术,经济和安全问题,以便广泛采用miRNA疗法.
主要方法:
- 对miRNA疗法进行的临床前和临床研究的综述.
- 在miRNA敏感性,特异性,传递和免疫性方面的挑战分析.
- 评估临床翻译的技术和经济可行性.
主要成果:
- miRNA疗法在临床前显著有前途,但在临床转化方面面临挑战.
- 很少有基于miRNA的疗法已经进入临床试验,没有一种达到III期或FDA批准.
- 毒性,非目标效应,输送和剂量仍然是miRNA治疗开发的重大障碍.
结论:
- 尽管面临挑战,但miRNA疗法在治疗包括癌症在内的各种疾病方面具有相当大的潜力.
- 解决特异性,输送,免疫性和了解miRNA功能的问题对于临床成功至关重要.
- 持续的研究和风险评估对于实现miRNAs的治疗应用至关重要.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:30siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:23RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K